Philip Needleman
Philip Needleman · Science & Medicine
Pharmacologist who discovered the COX-2 enzyme, leading to a new class of anti-inflammatory drugs.
1939, Brooklyn, New York, United States — 2024, St. Louis, Missouri, United States
United States
Philip Needleman is recognized among Jewish contributors to Science & Medicine — Pharmacologist who discovered the COX-2 enzyme, leading to a new class of anti-inflammatory drugs.
Needleman was an American pharmacologist and pharmaceutical executive who discovered the inducible COX-2 enzyme, opening the way to a new class of anti-inflammatory drugs including Celebrex. He chaired pharmacology at Washington University in St. Louis and led R&D at Monsanto/Searle; born into a Jewish family, he was Jewish.
Verify and go deeper with these external references.
Source: Jinfo.org — Jews in Biology
Pharmacologist who discovered the COX-2 enzyme, leading to a new class of anti-inflammatory drugs.
Source: Jinfo.org — Jews in Biology
Similar Contributors
Alfred Goldberg
Hans Kosterlitz
Salvador Moncada
Judith Klinman
Elie Metchnikoff
